Add time:07/23/2019         Source:sciencedirect.com

A novel series of HDAC inhibitors demonstrating class I and IIb subtype selectivity have been identified using a scaffold-hopping strategy. Several designed compounds showed better selectivity for class I and IIb over class IIa HDAC isoforms comparing to the FDA approved HDAC targeting drug SAHA. A representative lead compound 22 bearing a biphenyl moiety demonstrated promising class I and IIb HDAC isoforms selectivity and in vitro anticancer activities against several cancer cell lines. This work could serve as a fundamental platform for further exploration of selective HDAC inhibitors using designed molecular scaffold.

We also recommend Trading Suppliers and Manufacturers of 1-[3-(BROMOMETHYL)PHENYL]-1H-PYRROLE (cas 112596-36-8). Pls Click Website Link as below: cas 112596-36-8 suppliers